Celldex Therapeutics, Inc. (NASDAQ: CLDX) last traded at $28.25, down 4.01% on the session. The quote above updates while this page is open; the figures below are drawn from Celldex Therapeutics, Inc.’s own filings and are restated only when a new one is published.
Celldex Therapeutics, Inc. trades on NASDAQ under the ticker CLDX. Its market capitalisation is $2.22 billion.
Valuation measures for Celldex Therapeutics, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $2.22B |
|---|---|
| Enterprise value | $2.24B |
| Price / sales | 1435.90 |
| Price / book | 3.10 |
| Beta | 1.23 |
Trailing-twelve-month figures tagged in Celldex Therapeutics, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $1.54M |
|---|---|
| Net income (TTM) | -$300.55M |
| EPS (TTM) | -$4.36 |
| Gross margin | 87.06% |
| Operating margin | -21089.26% |
| Return on equity | -42.06% |
| Cash | $47.45M |
Range and volume for CLDX over the past 52 weeks.
| 52-week high | $45.14 |
|---|---|
| 52-week low | $22.10 |
| Volume | 1.90M |
| Average volume | 1.34M |
| Previous close | $29.43 |
Invest a chosen dollar amount in Celldex Therapeutics, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CLDX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.